Tempus AI Operating Margin 2023-2025 | TEM

Current and historical operating margin for Tempus AI (TEM) over the last 10 years. The current operating profit margin for Tempus AI as of March 31, 2025 is -88.70%.
Tempus AI Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-03-31 $0.80B $-0.71B -87.94%
2024-12-31 $0.69B $-0.69B -99.57%
2024-09-30 $0.64B $-0.67B -104.37%
2024-06-30 $0.60B $-0.66B -110.74%
2024-03-31 $0.56B $-0.17B -30.60%
2023-12-31 $0.53B $-0.17B -32.52%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $10.119B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.774B 53.56
Hims & Hers Health (HIMS) United States $11.630B 121.74
Inspire Medical Systems (INSP) United States $4.616B 72.12
IRhythm Technologies (IRTC) United States $4.348B 0.00
Privia Health (PRVA) United States $2.829B 212.00
Enovis (ENOV) United States $1.955B 12.10
Clover Health Investments (CLOV) United States $1.926B 0.00
Schrodinger (SDGR) United States $1.732B 0.00
Phreesia (PHR) United States $1.434B 0.00
Azenta (AZTA) United States $1.154B 53.74
Omnicell (OMCL) United States $1.154B 20.35
10x Genomics (TXG) United States $1.016B 0.00
Fulgent Genetics (FLGT) United States $0.568B 0.00
Butterfly Network (BFLY) United States $0.530B 0.00
Talkspace (TALK) United States $0.512B 152.00
Veradigm (MDRX) United States $0.466B 0.00
Standard BioTools (LAB) United States $0.387B 0.00
TruBridge (TBRG) United States $0.381B 850.00
Claritev (CTEV) United States $0.344B 0.00
Health Catalyst (HCAT) United States $0.279B 0.00
Nyxoah SA (NYXH) Belgium $0.215B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.200B 0.00
Pulmonx (LUNG) United States $0.148B 0.00
American Well (AMWL) United States $0.106B 0.00
Retrieve Medical Holdings (RMHI) United States $0.094B 0.00
EUDA Health Holdings (EUDA) Singapore $0.092B 0.00
MDxHealth SA (MDXH) Belgium $0.081B 0.00
CareCloud (CCLD) United States $0.080B 3.03
111 (YI) China $0.064B 0.00
HeartBeam (BEAT) United States $0.063B 0.00
P3 Health Partners (PIII) United States $0.062B 0.00
Outset Medical (OM) United States $0.042B 0.00
Zepp Health (ZEPP) Netherlands $0.038B 0.00
Zhongchao (ZCMD) China $0.030B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.015B 0.00
Streamline Health Solutions (STRM) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00